GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Isodiol International Inc (OTCPK:ISOLF) » Definitions » Total Liabilities

Isodiol International (Isodiol International) Total Liabilities : $8.69 Mil (As of Dec. 2019)


View and export this data going back to 2014. Start your Free Trial

What is Isodiol International Total Liabilities?

Isodiol International's Total Liabilities for the quarter that ended in Dec. 2019 was $8.69 Mil.

Isodiol International's quarterly Total Liabilities declined from Jun. 2019 ($10.61 Mil) to Sep. 2019 ($10.60 Mil) and declined from Sep. 2019 ($10.60 Mil) to Dec. 2019 ($8.69 Mil).

Isodiol International's annual Total Liabilities increased from Mar. 2017 ($0.28 Mil) to Mar. 2018 ($5.18 Mil) and increased from Mar. 2018 ($5.18 Mil) to Mar. 2019 ($12.48 Mil).


Isodiol International Total Liabilities Historical Data

The historical data trend for Isodiol International's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Isodiol International Total Liabilities Chart

Isodiol International Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19
Total Liabilities
Get a 7-Day Free Trial 0.33 0.93 0.28 5.18 12.48

Isodiol International Quarterly Data
Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 47.54 12.48 10.61 10.60 8.69

Isodiol International Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Isodiol International's Total Liabilities for the fiscal year that ended in Mar. 2019 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=8.597+(3.882+-0.00099999999999989
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=12.48

Total Liabilities=Total Assets (A: Mar. 2019 )-Total Equity (A: Mar. 2019 )
=17.664-5.185
=12.48

Isodiol International's Total Liabilities for the quarter that ended in Dec. 2019 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=4.379+(4.31+8.8817841970013E-16
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=8.69

Total Liabilities=Total Assets (Q: Dec. 2019 )-Total Equity (Q: Dec. 2019 )
=8.374--0.314
=8.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Isodiol International Total Liabilities Related Terms

Thank you for viewing the detailed overview of Isodiol International's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Isodiol International (Isodiol International) Business Description

Traded in Other Exchanges
N/A
Address
200 Granville Street, Suite 2710, Vancouver, BC, CAN, V6C 1S4
Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.

Isodiol International (Isodiol International) Headlines

From GuruFocus